English
中文
Top search
Atopic dermatitis Chronic prurigo Epidermolysis bullosa Psoriasis Immune-mediated kidney disease Glaucoma
Scientific Research Therapeutic Area
Scientific and technological innovation Therapeutic area Product lines Win-win cooperation
Therapeutic Area
Atopic dermatitis (AD) Chronic prurigo Membranous nephropathy Psoriasis Epidermolysis Bullosa (EB) Glaucoma
Epidermolysis Bullosa (EB)
Epidermolysis Bullosa (EB)
Concept
Epidermolysis bullosa (EB) refers to a set of heterogeneous genodermatosis with which vesicle will be caused by minor trauma of skin or mucous membrane. The main types include simplex type, borderline type, dystrophic type, and variant type.
Pathogenesis
Gene mutation is the pathogenesis of this disease, and mutation site determines lesion site.
Clinical manifestation
Skin fragility increases, skin layering will be caused just by gentle friction on skin, and tension vesicle, erosion and escharosis are usually formed within minutes. The cicatrix is usually atrophic in most cases.
Therapeutic measures
There is no particularly effective therapeutic method at the time. The important point is to prevent mechanical injury and infection.
About us
Approaching PrimeGene Coporate culture Development course Top management Honors & qualifications
Scientific research
Scientific and technological innovation Therapeutic area Product lines Win-win cooperation
News
Company News Industry trends
Recruitment
Philosophy on personnel Job duties
Get in touch with us
Floor 5&6, Tower B, Chongxin Building, Hangfeng Road 13#, Fengtai District, Beijing
010-83141848
Copyright owner：Prime Gene Therapeutics Co.,Ltd.
Copyright © 2023 All Rights Reserved.京ICP备2022001152号-1
Contact us Sitemap Privacy policy Legal statement